A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

NCT00778102 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: 5-FU
DRUG: 5-FU
DRUG: 5-FU
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: bevacizumab [Avastin]

Sponsor

Hoffmann-La Roche